The effect of renal dysfunction on antimicrobial use measurements

Clinical Infectious Diseases

Volumn 35, Issue 12, 2002, Pages 1491-1497

  Zagorski, B M ^a,e   Trick, W E ^d   Schwartz, D N ^b,c   Wisniewski, M F ^c   Hershow, R C ^a   Fridkin, S K ^d   Weinstein, R A ^b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c Cook Co Bureau of Health Services ^*  (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFTRIAXONE; CREATININE; LEVOFLOXACIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTI-INFECTIVE AGENTS; DRUG UTILIZATION; FEMALE; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG;

EID: 0037115247     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/344753     Document Type: Article

References (15)

1. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17:552-7.
2. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5:1033-47.
3. The Chicago Antimicrobial Resistance Project. Available at: http://www.carp-net.org. Accessed on 26 November 2002.
4. National Nosocomial Infections Surveillance System Report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001; 29:404-21.
5. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in US hospitals: Project ICARE phase 2. Clin Infect Dis 1999; 29:245-52.
6. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998; 17:20-4.
7. Harbarth, S. Variation in antimicrobial utilization for febrile neutropenia in cancer patients. Infection 2000; 28:375-8.
8. Constant F, Guillemin F, Herbeth B, Collin JF, Boulange M. Measurement methods of drug consumption as secondary judgment criterion for clinical trials in chronic rheumatic diseases. Am J Epidemiol 1997; 145:826-33.
9. Bro F, Mabeck CE. Use of antibiotics in a general practice in Denmark: Prescribed daily dose, duration of treatment and number of treatments in general practice. Scand J Prim Health Care 1986; 4:101-4.
10. McEvoy GK, ed. American hospital formulary service drug information. Bethesda, MD: American Society of Health-System Pharmacists, 2001.
11. Carson RT. Compensating for missing data and invalid responses in contingent valuation surveys. In: Proceedings of the Survey Research Section of the American Statistical Association. Washington, DC: American Statistical Association, 1984.
12. Steinberg D, Carson R, Breiman L. Broad scale missing-value imputation with iterative binary partitioning. Comput Sci Stat 1998; 29:259-62.
13. Amsden GW, Schentag JJ. Tables of antimicrobial agent pharmacology. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th Ed. New York: Churchill Livingstone, 1995:492-528.
14. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
15. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE Randomized Trial. Ann Intern Med 2001; 134:629-36.